retatrutide liver disease STUDY: Novel “Triagonist” Resolved Steatosis in Over 85% of Patients with MASLD and Obesity Retatrutide: Eli Lilly's GLP-1 Triple
Description
I suspect the effect still exists, very interesting!
This was a randomized controlled trial of semaglutide for alcohol use disorder that included 48 non-treatment-seeking adults with alcohol use disorder, to test semaglutides effects on alcohol craving and consumption
This does not mean you need to force large meals or follow a complicated diet
However, analysts expect the cost of retatrutide to be similar to other premium GLP-1 medications already approved by the FDA
The risk is particularly high for developing spondyloarthritis, ankylosing spondylitis, and rheumatoid arthritis
